Circulating soluble CD4 directly prevents host resistance and delayed-type hypersensitivity response to Cryptococcus

K Kawakami1, Y Koguchi, M H Qureshi

  • 1The First Department of Internal Medicine, Faculty of Medicine, University of the Ryukyus, Nishihara, Okinawa, Japan. kawakami@med.u-ryukyu.ac.jp

Microbiology and Immunology
|February 28, 2001
PubMed

Insights

Soluble CD4 (sCD4) impairs host resistance and delayed-type hypersensitivity (DTH) to Cryptococcus neoformans by interfering with Th1 cytokine production. This highlights sCD4

Area of Science:

  • Immunology
  • Infectious Diseases
  • Microbiology

Background:

  • Cryptococcus neoformans is an opportunistic fungal pathogen that can cause life-threatening meningoencephalitis in immunocompromised individuals.
  • CD4+ T cells play a critical role in host defense against C. neoformans, primarily through the production of Th1 cytokines.
  • The role of soluble CD4 (sCD4) in modulating immune responses to C. neoformans remains incompletely understood.

Purpose of the Study:

  • To investigate the impact of soluble CD4 (sCD4) on host resistance and delayed-type hypersensitivity (DTH) to Cryptococcus neoformans.
  • To elucidate the mechanisms by which sCD4 influences immune responses against C. neoformans.
  • To determine whether circulating sCD4, rather than the absence of membrane-bound CD4, is responsible for immunodeficiency.

Main Methods:

  • Utilized a novel mutant mouse model with impaired membrane-bound CD4 expression but high serum sCD4 levels.
  • Administered anti-CD4 monoclonal antibody (mAb) to assess its effect on host defense.
  • Employed CD4 gene-disrupted (CD4KO) mice and sCD4 gene-transfected myeloma cells for mechanistic studies.
  • Evaluated host resistance by quantifying live C. neoformans in the lungs.
  • Assessed DTH response using footpad swelling assays.
  • Measured serum levels of Th1 (IFN-gamma, IL-12, IL-18) and Th2 (IL-4, IL-10) cytokines.

Main Results:

  • Mutant mice with high sCD4 levels exhibited impaired host resistance to C. neoformans, evidenced by increased pathogen burden in the lungs.
  • Administration of anti-CD4 mAb restored host defense in mutant mice.
  • CD4KO mice did not show attenuated host resistance, suggesting the lack of membrane-bound CD4 was not the cause of immunodeficiency.
  • Implantation of sCD4-transfected cells rendered CD4KO mice susceptible to infection, confirming sCD4's detrimental role.
  • DTH response to C. neoformans was reduced in mutant mice and restored by anti-CD4 mAb treatment.
  • Serum levels of Th1 cytokines (IFN-gamma, IL-12, IL-18) were significantly reduced in mutant mice, while Th2 cytokine levels remained unchanged.

Conclusions:

  • Circulating soluble CD4 (sCD4), not the absence of membrane-bound CD4, is responsible for the observed immunodeficiency in the mutant mice.
  • sCD4 directly impairs host resistance and DTH response to Cryptococcus neoformans.
  • The mechanism of sCD4-mediated immunodeficiency involves the suppression of Th1-type cytokine production.